Does Early PET/CT Assesment of Response to Chemotherapy Predicts Survival in Patients With Advanced Stage Non-Small-Cell Lung Cancer?


Creative Commons License

Ordu Ç., Selcuk N. A. , ERDOĞAN E. B. , Angın G., Güral Z., Memiş H., ...Daha Fazla

MEDICINE, cilt.93, sa.28, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 93 Konu: 28
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1097/md.0000000000000299
  • Dergi Adı: MEDICINE

Özet

The aim of this study is to determine the prognostic role and the timing of metabolic response to chemotherapy, based on F-18-fluorodeoxyglucose positron emission tomography (F-18-FDG-PET), in patients with metastatic non-small-cell lung cancer (NSCLC).